An estimated 2.5 million people are living with multiple sclerosis, an incurable neurological condition. About 200 new cases are diagnosed each week in the U.S.A.

MS occurs when the immune system attacks the protective sleeve surrounding nerve fibers and brain cells, known as a myelin sheath, resulting in an intractable breakdown of the nervous system.

Mounting scientific evidence is demonstrating that epsilon toxin-producing Clostridium perfringens may be the long sought-after trigger that degrades the blood-brain barrier and kicks off the relentless inflammation and brain cell degradation characteristic of multiple sclerosis.

C. perfringens is an anaerobic pathogen that causes gas gangrene, food poisoning and enteritis necroticans (Pigbel). Oxygen is toxic to C. perfringens and inhibits clostridial toxin production, making SIDIPREV™ a potential MS treatment.